Breaking News Instant updates and real-time market news.

10:02
01/22/21
01/22
10:02
01/22/21
10:02

Existing Home Sales Annual Rate data reported

December Existing Home Sales Annual Rate at 6.760M vs. consensus of 6.550M

TODAY'S FREE FLY STORIES

Syndicate
Edesa Biotech announces $3.5M bought deal offering of common shares » 17:14
02/25/21
02/25
17:14
02/25/21
17:14
EDSA

Edesa Biotech

$6.60 /

+0.2 (+3.13%)

Edesa Biotech announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EDSA Edesa Biotech
$6.60 /

+0.2 (+3.13%)

EDSA Edesa Biotech
$6.60 /

+0.2 (+3.13%)

03/30/20 Brookline
Edesa Biotech initiated with a Buy at Brookline
Earnings
Vicor reports Q4 EPS 25c, consensus 17c » 17:13
02/25/21
02/25
17:13
02/25/21
17:13
VICR

Vicor

$90.00 /

-5.23 (-5.49%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VICR Vicor
$90.00 /

-5.23 (-5.49%)

VICR Vicor
$90.00 /

-5.23 (-5.49%)

12/30/20 Needham
Needham names Applied Materials top pick in 2021, boosts price target to $110
10/23/20 Needham
Vicor price target raised to $95 from $85 at Needham
09/18/20 Northland
Combined Nvidia-ARM a long-term risk for AMD, Intel and Vicor, says Northland
07/24/20 BWS Financial
Vicor price target raised to $100 from $84 at BWS Financial
VICR Vicor
$90.00 /

-5.23 (-5.49%)

  • 11
    Jun
Earnings
Mirati Therapeutics reports Q4 EPS ($2.08), consensus (2.23) » 17:13
02/25/21
02/25
17:13
02/25/21
17:13
MRTX

Mirati Therapeutics

$195.44 /

-6.96 (-3.44%)

Reports Q4 revenue $1.7M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRTX Mirati Therapeutics
$195.44 /

-6.96 (-3.44%)

MRTX Mirati Therapeutics
$195.44 /

-6.96 (-3.44%)

01/15/21 H.C. Wainwright
Mirati Therapeutics price target lowered to $257 from $265 at H.C. Wainwright
12/08/20 JMP Securities
Mirati Therapeutics initiated with a Market Perform at JMP Securities
11/17/20 BofA
Mirati Therapeutics downgraded to Underperform from Neutral at BofA
11/10/20 Guggenheim
Mirati Therapeutics downgraded to Neutral from Buy at Guggenheim
MRTX Mirati Therapeutics
$195.44 /

-6.96 (-3.44%)

  • 28
    Oct
MRTX Mirati Therapeutics
$195.44 /

-6.96 (-3.44%)

Syndicate
AvalonBay files automatic mixed securities shelf  17:12
02/25/21
02/25
17:12
02/25/21
17:12
AVB

AvalonBay

$180.39 /

-4.67 (-2.52%)

 
ShowHide Related Items >><<
AVB AvalonBay
$180.39 /

-4.67 (-2.52%)

AVB AvalonBay
$180.39 /

-4.67 (-2.52%)

02/22/21 KeyBanc
AvalonBay upgraded to Overweight at KeyBanc on coastal recovery
02/21/21 KeyBanc
AvalonBay upgraded to Overweight from Sector Weight at KeyBanc
02/09/21 BofA
Camden Property downgraded to Neutral from Buy at BofA
12/21/20 JPMorgan
JPMorgan changes ratings in REIT, Real Estate Services sectors into 2021
AVB AvalonBay
$180.39 /

-4.67 (-2.52%)

Conference/Events
Viatris to host virtual investor day » 17:11
02/25/21
02/25
17:11
02/25/21
17:11
VTRS

Viatris

$15.05 /

-0.245 (-1.60%)

Virtual Investor Day to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VTRS Viatris
$15.05 /

-0.245 (-1.60%)

VTRS Viatris
$15.05 /

-0.245 (-1.60%)

02/23/21 Barclays
Viatris price target lowered to $20 from $26 at Barclays
01/06/21 RBC Capital
Viatris named one of top stocks to own in 2021 by RBC Capital
01/05/21 Argus
Viatris initiated with a Hold at Argus
12/14/20 Bernstein
Viatris initiated with a Market Perform at Bernstein
VTRS Viatris
$15.05 /

-0.245 (-1.60%)

VTRS Viatris
$15.05 /

-0.245 (-1.60%)

Hot Stocks
Beyond Meat says 'not prepared to elaborate' on new partnerships » 17:11
02/25/21
02/25
17:11
02/25/21
17:11
BYND

Beyond Meat

$143.89 /

-8.21 (-5.40%)

Says plans to hold…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BYND Beyond Meat
$143.89 /

-8.21 (-5.40%)

BYND Beyond Meat
$143.89 /

-8.21 (-5.40%)

02/03/21
Fly Intel: Top five analyst downgrades
02/03/21 DA Davidson
Beyond Meat downgraded to Underperform from Neutral at DA Davidson
02/03/21 DA Davidson
Beyond Meat downgraded to Underperform from Neutral at DA Davidson
01/27/21 Canaccord
Beyond Meat price target raised to $170 from $125 at Canaccord
BYND Beyond Meat
$143.89 /

-8.21 (-5.40%)

BYND Beyond Meat
$143.89 /

-8.21 (-5.40%)

BYND Beyond Meat
$143.89 /

-8.21 (-5.40%)

BYND Beyond Meat
$143.89 /

-8.21 (-5.40%)

Earnings
AnaptysBio reports Q4 EPS $1.20, consensus $1.39 » 17:11
02/25/21
02/25
17:11
02/25/21
17:11
ANAB

AnaptysBio

$26.00 /

-0.39 (-1.48%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANAB AnaptysBio
$26.00 /

-0.39 (-1.48%)

ANAB AnaptysBio
$26.00 /

-0.39 (-1.48%)

02/11/21 JPMorgan
JPMorgan double upgrades AnaptysBio, more than doubles price target
02/11/21 JPMorgan
AnaptysBio upgraded to Overweight from Underweight at JPMorgan
10/27/20
Fly Intel: Top five analyst upgrades
10/27/20 Truist
AnaptysBio price target raised to $27 from $20 at Truist
ANAB AnaptysBio
$26.00 /

-0.39 (-1.48%)

ANAB AnaptysBio
$26.00 /

-0.39 (-1.48%)

Earnings
Erie Indemnity reports Q4 EPS $1.20 , consensus $1.21 » 17:11
02/25/21
02/25
17:11
02/25/21
17:11
ERIE

Erie Indemnity

$243.85 /

-4.15 (-1.67%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ERIE Erie Indemnity
$243.85 /

-4.15 (-1.67%)

ERIE Erie Indemnity
$243.85 /

-4.15 (-1.67%)

Earnings
Nektar reports Q4 EPS (65c), consensus (68c) » 17:09
02/25/21
02/25
17:09
02/25/21
17:09
NKTR

Nektar

$22.47 /

-0.29 (-1.27%)

Reports Q4 revenue $23.5…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKTR Nektar
$22.47 /

-0.29 (-1.27%)

NKTR Nektar
$22.47 /

-0.29 (-1.27%)

02/22/21 Benchmark
Nektar downgraded to Hold on valuation at Benchmark
02/22/21 Benchmark
Nektar downgraded to Hold from Buy at Benchmark
02/17/21 William Blair
William Blair 'highly encouraged' by Nektar's collaborations with Merk, SFJ
02/17/21 Piper Sandler
Nektar collaborations could create $500M-$800M opportunity, says Piper Sandler
NKTR Nektar
$22.47 /

-0.29 (-1.27%)

Earnings
Codexis sees FY21 revenue $82M-$85M, consensus $80.53M » 17:08
02/25/21
02/25
17:08
02/25/21
17:08
CDXS

Codexis

$21.23 /

-1.67 (-7.29%)

Sees FY21 adjusted gross…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CDXS Codexis
$21.23 /

-1.67 (-7.29%)

CDXS Codexis
$21.23 /

-1.67 (-7.29%)

12/30/20 Benchmark
Codexis price target raised to $29 from $21 at Benchmark
07/15/20 Stephens
Codexis resumed with an Overweight at Stephens
03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
CDXS Codexis
$21.23 /

-1.67 (-7.29%)

  • 03
    Dec
CDXS Codexis
$21.23 /

-1.67 (-7.29%)

Earnings
Assembly Biosciences reports Q4 EPS ($1.75), consensus (90c) » 17:08
02/25/21
02/25
17:08
02/25/21
17:08
ASMB

Assembly Biosciences

$5.53 /

-0.13 (-2.30%)

"Our strategy for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASMB Assembly Biosciences
$5.53 /

-0.13 (-2.30%)

ASMB Assembly Biosciences
$5.53 /

-0.13 (-2.30%)

12/04/20 Mizuho
Assembly Biosciences price target lowered to $13 from $30 at Mizuho
11/06/20 Jefferies
Assembly Biosciences downgraded to Hold from Buy at Jefferies
10/19/20 Truist
Assembly Biosciences initiated with a Buy at Truist
07/21/20 Baird
Assembly Biosciences HBV deal a positive, says Baird
ASMB Assembly Biosciences
$5.53 /

-0.13 (-2.30%)

ASMB Assembly Biosciences
$5.53 /

-0.13 (-2.30%)

Earnings
Pembina Pipeline reports Q4 EPS ($2.28), may not compare to consensus 44c » 17:08
02/25/21
02/25
17:08
02/25/21
17:08
PBA

Pembina Pipeline

$27.50 /

-0.645 (-2.29%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PBA Pembina Pipeline
$27.50 /

-0.645 (-2.29%)

PBA Pembina Pipeline
$27.50 /

-0.645 (-2.29%)

02/09/21 Scotiabank
Pembina Pipeline downgraded to Sector Perform from Outperform at Scotiabank
01/27/21 Credit Suisse
Pembina Pipeline price target raised to C$42 from C$40 at Credit Suisse
01/27/21 National Bank
Pembina Pipeline price target raised to C$38 from C$36 at National Bank
01/22/21 Stifel
Pembina Pipeline price target raised to C$37 from C$34 at Stifel
Earnings
Ranger Energy reports Q4 EPS (43c), consensus (31c) » 17:06
02/25/21
02/25
17:06
02/25/21
17:06
RNGR

Ranger Energy

$5.54 /

+0.09 (+1.65%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RNGR Ranger Energy
$5.54 /

+0.09 (+1.65%)

01/04/21 Evercore ISI
Ranger Energy upgraded to Outperform from In Line at Evercore ISI
12/10/20 B. Riley Securities
Ranger Energy upgraded to Buy on valuation at B. Riley Securities
12/10/20 B. Riley Securities
Ranger Energy upgraded to Buy from Neutral at B. Riley Securities
04/15/20 Piper Sandler
Ranger Energy downgraded to Neutral from Overweight at Piper Sandler
RNGR Ranger Energy
$5.54 /

+0.09 (+1.65%)

Earnings
Fly Leasing reports Q4 adjusted EPS ($3.78), consensus (15c) » 17:06
02/25/21
02/25
17:06
02/25/21
17:06
FLY

Fly Leasing

$12.42 /

-0.19 (-1.51%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FLY Fly Leasing
$12.42 /

-0.19 (-1.51%)

FLY Fly Leasing
$12.42 /

-0.19 (-1.51%)

01/26/21 Cowen
Fly Leasing price target raised to $13 from $9 at Cowen
01/25/21 Deutsche Bank
Fly Leasing price target raised to $11 from $8.50 at Deutsche Bank
11/16/20 Deutsche Bank
Fly Leasing price target lowered to $8.50 from $10 at Deutsche Bank
05/26/20 JPMorgan
JPMorgan upgrades Fly Leasing with stock rally lagging peers
FLY Fly Leasing
$12.42 /

-0.19 (-1.51%)

FLY Fly Leasing
$12.42 /

-0.19 (-1.51%)

Earnings
Codexis reports Q4 EPS (6c), consensus (12c) » 17:06
02/25/21
02/25
17:06
02/25/21
17:06
CDXS

Codexis

$21.23 /

-1.67 (-7.29%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CDXS Codexis
$21.23 /

-1.67 (-7.29%)

CDXS Codexis
$21.23 /

-1.67 (-7.29%)

12/30/20 Benchmark
Codexis price target raised to $29 from $21 at Benchmark
07/15/20 Stephens
Codexis resumed with an Overweight at Stephens
03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
CDXS Codexis
$21.23 /

-1.67 (-7.29%)

  • 03
    Dec
CDXS Codexis
$21.23 /

-1.67 (-7.29%)

Hot Stocks
Southwest Gas sees FY21 CapEx approximately $700M  17:05
02/25/21
02/25
17:05
02/25/21
17:05
SWX

Southwest Gas

$64.17 /

-0.955 (-1.47%)

 
ShowHide Related Items >><<
SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

01/29/21
Fly Intel: Top five analyst downgrades
01/29/21 JPMorgan
Southwest Gas downgraded to Neutral on regulatory risk at JPMorgan
01/29/21 JPMorgan
Southwest Gas downgraded to Neutral from Overweight at JPMorgan
12/10/20 BofA
Southwest Gas cut to Underperform at BofA after AZ rate case decision
SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

Earnings
Southwest Gas sees FY21 EPS $3.95-$4.20, consensus $4.18  17:05
02/25/21
02/25
17:05
02/25/21
17:05
SWX

Southwest Gas

$64.17 /

-0.955 (-1.47%)

 
ShowHide Related Items >><<
SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

01/29/21
Fly Intel: Top five analyst downgrades
01/29/21 JPMorgan
Southwest Gas downgraded to Neutral on regulatory risk at JPMorgan
01/29/21 JPMorgan
Southwest Gas downgraded to Neutral from Overweight at JPMorgan
12/10/20 BofA
Southwest Gas cut to Underperform at BofA after AZ rate case decision
SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

Earnings
Southwest Gas reports Q4 EPS $1.82, consensus $1.61 » 17:04
02/25/21
02/25
17:04
02/25/21
17:04
SWX

Southwest Gas

$64.17 /

-0.955 (-1.47%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

01/29/21
Fly Intel: Top five analyst downgrades
01/29/21 JPMorgan
Southwest Gas downgraded to Neutral on regulatory risk at JPMorgan
01/29/21 JPMorgan
Southwest Gas downgraded to Neutral from Overweight at JPMorgan
12/10/20 BofA
Southwest Gas cut to Underperform at BofA after AZ rate case decision
SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

Earnings
PetIQ reports Q4 EPS (41c), consensus (10c) » 17:04
02/25/21
02/25
17:04
02/25/21
17:04
PETQ

PetIQ

$37.25 /

+1.77 (+4.99%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PETQ PetIQ
$37.25 /

+1.77 (+4.99%)

PETQ PetIQ
$37.25 /

+1.77 (+4.99%)

10/15/20 Jefferies
PetIQ assumed with a Buy at Jefferies
08/17/20 Guggenheim
Zoetis price target raised to $175 from $139 at Guggenheim
07/01/20 Raymond James
PetIQ price target raised to $41 from $35 at Raymond James
06/25/20 Guggenheim
PetIQ price target raised to $44 from $33.50 at Guggenheim
PETQ PetIQ
$37.25 /

+1.77 (+4.99%)

PETQ PetIQ
$37.25 /

+1.77 (+4.99%)

Hot Stocks
Sallie Mae increases price range, extends expiration to buy up to $1B in stock » 17:04
02/25/21
02/25
17:04
02/25/21
17:04
SLM

Sallie Mae

$14.99 /

-0.23 (-1.51%)

Sallie Mae announced it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLM Sallie Mae
$14.99 /

-0.23 (-1.51%)

SLM Sallie Mae
$14.99 /

-0.23 (-1.51%)

01/29/21 Barclays
Sallie Mae price target raised to $18 from $15 at Barclays
01/29/21 RBC Capital
Sallie Mae upgraded to Outperform from Sector Perform at RBC Capital
01/29/21 Citi
Sallie Mae price target raised to $16 from $12 at Citi
01/29/21 RBC Capital
Sallie Mae upgraded to Outperform from Sector Perform at RBC Capital
SLM Sallie Mae
$14.99 /

-0.23 (-1.51%)

SLM Sallie Mae
$14.99 /

-0.23 (-1.51%)

SLM Sallie Mae
$14.99 /

-0.23 (-1.51%)

Earnings
Cardiff Oncology reports Q4 EPS (19c), consensus (14c) » 17:04
02/25/21
02/25
17:04
02/25/21
17:04
CRDF

Cardiff Oncology

$9.78 /

-0.52 (-5.05%)

Reports Q4 revenue $119K,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRDF Cardiff Oncology
$9.78 /

-0.52 (-5.05%)

CRDF Cardiff Oncology
$9.78 /

-0.52 (-5.05%)

02/11/21 Piper Sandler
Piper says Cardiff Oncology mCRPC opportunity 'more interesting' after data
10/22/20
Fly Intel: Top five analyst initiations
10/22/20 H.C. Wainwright
Cardiff Oncology initiated with a Buy at H.C. Wainwright
10/21/20 Maxim
Cardiff Oncology price target raised to $20 from $14 at Maxim
CRDF Cardiff Oncology
$9.78 /

-0.52 (-5.05%)

  • 30
    Sep
CRDF Cardiff Oncology
$9.78 /

-0.52 (-5.05%)

CRDF Cardiff Oncology
$9.78 /

-0.52 (-5.05%)

Hot Stocks
Vivint Smart Home sues ADT for patent infringement » 17:04
02/25/21
02/25
17:04
02/25/21
17:04
VVNT

Vivint Smart Home

$17.37 /

-2.02 (-10.42%)

, ADT

ADT Inc.

$9.48 /

-0.77 (-7.51%)

Vivint Smart Home (VVNT)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VVNT Vivint Smart Home
$17.37 /

-2.02 (-10.42%)

ADT ADT Inc.
$9.48 /

-0.77 (-7.51%)

VVNT Vivint Smart Home
$17.37 /

-2.02 (-10.42%)

07:11 Today Deutsche Bank
Vivint Smart Home price target lowered to $21 from $24 at Deutsche Bank
01/15/21 Deutsche Bank
Vivint Smart Home downgraded to Hold on valuation at Deutsche Bank
01/15/21 Deutsche Bank
Vivint Smart Home downgraded to Hold from Buy at Deutsche Bank
11/05/20 JPMorgan
Vivint Smart Home price target raised to $34 from $30 at JPMorgan
ADT ADT Inc.
$9.48 /

-0.77 (-7.51%)

01/29/21 Citi
ADT Inc. downgraded to Neutral from Buy at Citi
01/29/21 Citi
ADT Inc. downgraded to Neutral from Buy at Citi
01/15/21 Deutsche Bank
ADT Inc. assumed with a Hold at Deutsche Bank
11/06/20 Roth Capital
Alarm.com price target raised to $75 from $65 at Roth Capital
VVNT Vivint Smart Home
$17.37 /

-2.02 (-10.42%)

ADT ADT Inc.
$9.48 /

-0.77 (-7.51%)

  • 16
    Sep
ADT ADT Inc.
$9.48 /

-0.77 (-7.51%)

VVNT Vivint Smart Home
$17.37 /

-2.02 (-10.42%)

ADT ADT Inc.
$9.48 /

-0.77 (-7.51%)

Earnings
Acadia sees FY21 EPS $2.20-$2.45, consensus $2.56 » 17:02
02/25/21
02/25
17:02
02/25/21
17:02
ACHC

Acadia

$51.35 /

-3.16 (-5.80%)

Sees FY21 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACHC Acadia
$51.35 /

-3.16 (-5.80%)

ACHC Acadia
$51.35 /

-3.16 (-5.80%)

12/31/20 Credit Suisse
Acadia price target raised to $44 from $36 at Credit Suisse
12/30/20 Jefferies
Jefferies ups Acadia price target to $60 on better than expected UK deal terms
12/18/20 Mizuho
Acadia price target raised to $50 from $35 at Mizuho
11/17/20 UBS
Acadia upgraded to Buy from Neutral at UBS
ACHC Acadia
$51.35 /

-3.16 (-5.80%)

Earnings
Atreca reports Q4 EPS (63c), consensus (64c) » 17:02
02/25/21
02/25
17:02
02/25/21
17:02
BCEL

Atreca

$17.84 /

-0.5 (-2.73%)

"2020 was a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BCEL Atreca
$17.84 /

-0.5 (-2.73%)

02/08/21 Jefferies
Atreca initiated with a Buy at Jefferies
08/12/20 Stifel
Volatility in Atreca shares creates 'interesting' opportunity, says Stifel
07/08/20 Piper Sandler
Xencor, Atreca deal offers synergies for XmAb design, says Piper Sandler
07/01/20 Canaccord
Atreca price target raised to $33 from $23 at Canaccord
BCEL Atreca
$17.84 /

-0.5 (-2.73%)

  • 16
    Jul
Earnings
Fidus Investment reports Q4 adjusted EPS 44c, consensus 35c » 17:02
02/25/21
02/25
17:02
02/25/21
17:02
FDUS

Fidus Investment

$14.57 /

-0.1 (-0.68%)

Reports Q4 NAV per share…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FDUS Fidus Investment
$14.57 /

-0.1 (-0.68%)

11/24/20 B. Riley Securities
Fidus Investment price target raised to $12 from $10 at B. Riley Securities
08/10/20 Ladenburg
Fidus Investment upgraded to Buy at Ladenburg with credit holding up well
08/10/20 Ladenburg
Fidus Investment upgraded to Buy from Neutral at Ladenburg
03/24/20 B. Riley FBR
Fidus Investment downgraded to Neutral from Buy at B. Riley FBR
FDUS Fidus Investment
$14.57 /

-0.1 (-0.68%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.